Morphic (MORF) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free MORF Stock Alerts $29.13 -0.20 (-0.68%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Morphic Short Interest DataCurrent Short Volume6,250,000 sharesPrevious Short Volume5,900,000 sharesChange Vs. Previous Month+5.93%Dollar Volume Sold Short$184.44 millionShort Interest Ratio / Days to Cover12.7Last Record DateApril 15, 2024Outstanding Shares50,090,000 sharesPercentage of Shares Shorted12.48%Today's Trading Volume281,791 sharesAverage Trading Volume492,008 sharesToday's Volume Vs. Average57% Short Selling Morphic ? Sign up to receive the latest short interest report for Morphic and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMORF Short Interest Over TimeMORF Days to Cover Over TimeMORF Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Morphic Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,250,000 shares $184.44 million +5.9%N/A12.7 $29.51 3/31/20245,900,000 shares $207.68 million -3.9%N/A11.4 $35.20 3/15/20246,140,000 shares $212.14 million +1.8%N/A11.5 $34.55 2/29/20246,030,000 shares $222.81 million +2.2%N/A9.9 $36.95 2/15/20245,900,000 shares $228.04 million -2.2%N/A9.6 $38.65 1/31/20246,030,000 shares $191.09 million +4.3%N/A10.1 $31.69 Get the Latest News and Ratings for MORF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,780,000 shares $160.63 million +3.4%N/A10 $27.79 12/31/20235,590,000 shares $161.44 million -5.9%N/A8.1 $28.88 12/15/20235,940,000 shares $184.14 million -7.9%N/A6.1 $31.00 11/30/20236,450,000 shares $152.87 million +5.6%N/A5.7 $23.70 11/15/20236,110,000 shares $142.24 million -6.6%N/A5.6 $23.28 10/31/20236,540,000 shares $130.47 million +20.4%N/A6.1 $19.95 10/15/20235,430,000 shares $117.45 million +10.6%N/A5.2 $21.63 9/30/20234,910,000 shares $112.49 million +51.5%N/A5.3 $22.91 9/15/20233,240,000 shares $172.43 million +14.1%N/A4.9 $53.22 8/31/20232,840,000 shares $156.43 million +8.4%N/A7 $55.08 8/15/20232,620,000 shares $139.91 million +10.6%N/A6 $53.40 7/31/20232,370,000 shares $134.45 million -10.9%6.6%5.2 $56.73 7/15/20232,660,000 shares $156.75 million +9.5%7.9%4.3 $58.93 6/30/20232,430,000 shares $139.31 million -3.2%7.2%3.9 $57.33 6/15/20232,510,000 shares $148.92 million +6.8%7.5%4 $59.33 5/31/20232,350,000 shares $135.13 million -9.6%7.3%4 $57.50 5/15/20232,600,000 shares $149.60 million +19.3%8.1%4.4 $57.54 4/30/20232,180,000 shares $103.03 million +19.1%6.7%3.7 $47.26 4/15/20231,830,000 shares $63.39 million +2.8%6.2%4.8 $34.64 3/31/20231,780,000 shares $67.00 million -27.6%6.1%4.8 $37.64 3/15/20232,460,000 shares $104.06 million +4.2%8.4%7.1 $42.30 2/28/20232,360,000 shares $100.35 million -1.7%8.1%7.9 $42.52 2/15/20232,400,000 shares $95.86 million -26.2%8.4%9 $39.94 1/31/20233,250,000 shares $106.37 million -6.3%11.1%13.4 $32.73 1/15/20233,470,000 shares $110.07 million -2.8%11.9%14.1 $31.72 12/30/20223,570,000 shares $95.50 million +2.9%12.2%14.9 $26.75 12/15/20223,470,000 shares $93.76 million No Change11.9%13.4 $27.02 11/30/20223,470,000 shares $95.49 million -0.3%11.9%12.2 $27.52 11/15/20223,480,000 shares $104.33 million -3.6%11.9%11.7 $29.98 10/31/20223,610,000 shares $101.12 million +0.3%12.8%11.6 $28.01 10/15/20223,600,000 shares $100.04 million +4.4%12.8%11.1 $27.79 9/30/20223,450,000 shares $97.64 million -4.2%12.3%10.3 $28.30 9/15/20223,600,000 shares $106.24 million +5.3%12.8%10.3 $29.51 8/31/20223,420,000 shares $94.12 million -1.7%12.2%9.3 $27.52The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. MORF Short Interest - Frequently Asked Questions What is Morphic's current short interest? Short interest is the volume of Morphic shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 6,250,000 shares of MORF short. Learn More on Morphic's current short interest. What is a good short interest ratio for Morphic? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MORF shares currently have a short interest ratio of 13.0. Learn More on Morphic's short interest ratio. Is Morphic's short interest increasing or decreasing? Morphic saw a increase in short interest in April. As of April 15th, there was short interest totaling 6,250,000 shares, an increase of 5.9% from the previous total of 5,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Morphic's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Morphic: Protagonist Therapeutics, Inc. (6.00%), Akero Therapeutics, Inc. (11.83%), Xencor, Inc. (10.09%), Day One Biopharmaceuticals, Inc. (15.17%), Dynavax Technologies Co. (14.17%), Kiniksa Pharmaceuticals, Ltd. (5.13%), Taro Pharmaceutical Industries Ltd. (0.58%), Arcus Biosciences, Inc. (14.45%), Kura Oncology, Inc. (15.93%), ANI Pharmaceuticals, Inc. (1.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Morphic stock? Short selling MORF is an investing strategy that aims to generate trading profit from Morphic as its price is falling. MORF shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Morphic? A short squeeze for Morphic occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MORF, which in turn drives the price of the stock up even further. How often is Morphic's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MORF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PTGX Short Interest AKRO Short Interest XNCR Short Interest DAWN Short Interest DVAX Short Interest KNSA Short Interest TARO Short Interest RCUS Short Interest KURA Short Interest ANIP Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MORF) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & Company